This impurity is related to Valaciclovir EP Impurity A is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.

 
    
     
 
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                         
                    
                        
                        